On the public citation graph

Pteryxin - A promising butyrylcholinesterase-inhibiting coumarin derivative from Mutellina purpurea

https://doi.org/10.1016/j.fct.2017.03.016

0 signed · 78 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1007/bf02906767openalex-snapshot

Extractive studies of the roots of Pteryxia terebinthina var. terebinthina and the isolation of Pteryxin

inferredcites →https://doi.org/10.1016/0006-2952(61)90145-9openalex-snapshot

A new and rapid colorimetric determination of acetylcholinesterase activity

inferredcites →https://doi.org/10.1016/j.bioorg.2015.08.002openalex-snapshot

Synthesis, molecular docking, acetylcholinesterase and butyrylcholinesterase inhibitory potential of thiazole analogs as new inhibitors for Alzheimer disease

inferredcites →https://doi.org/10.1016/j.bmc.2005.08.038openalex-snapshot

Inhibitory effects of coumarin and acetylene constituents from the roots of Angelica furcijuga on d-galactosamine/lipopolysaccharide-induced liver injury in mice and on nitric oxide production in lipopolysaccharide-activated mouse peritoneal macrophages

inferredcites →https://doi.org/10.1016/j.cbi.2016.05.001openalex-snapshot

Coumarins as cholinesterase inhibitors: A review

inferredcites →https://doi.org/10.1016/j.ejmech.2014.05.056openalex-snapshot

Synthesis and anti-cholinesterase activity of new 7-hydroxycoumarin derivatives

inferredcites →https://doi.org/10.1016/j.foodchem.2013.12.026openalex-snapshot

Quantitative analysis of phenolic metabolites from different parts of Angelica keiskei by HPLC–ESI MS/MS and their xanthine oxidase inhibition

inferredcites →https://doi.org/10.1016/j.jep.2013.12.053openalex-snapshot

The treatment of Alzheimer's disease using Chinese Medicinal Plants: From disease models to potential clinical applications

inferredcites →https://doi.org/10.1016/j.jff.2016.11.030openalex-snapshot

In vivo and in vitro anti-obesity activities of dihydropyranocoumarins derivatives from Peucedanum japonicum Thunb

inferredcites →https://doi.org/10.1016/j.nut.2014.01.015openalex-snapshot

Pteryxin: A coumarin in Peucedanum japonicum Thunb leaves exerts antiobesity activity through modulation of adipogenic gene network

inferredcites →https://doi.org/10.1016/j.phytol.2011.08.016openalex-snapshot

An in vitro and in silico approach to cholinesterase inhibitory and antioxidant effects of the methanol extract, furanocoumarin fraction, and major coumarins of Angelica officinalis L. fruits

inferredcites →https://doi.org/10.1021/jm300871xopenalex-snapshot

Structures of Human Acetylcholinesterase in Complex with Pharmacologically Important Ligands

inferredcites →https://doi.org/10.1021/jm501195eopenalex-snapshot

Discovery, Biological Evaluation, and Crystal Structure of a Novel Nanomolar Selective Butyrylcholinesterase Inhibitor

inferredcites →https://doi.org/10.1021/np000441wopenalex-snapshot

Coumarins Isolated from Angelica gigas Inhibit Acetylcholinesterase: Structure−Activity Relationships

inferredcites →https://doi.org/10.1055/s-0042-108738openalex-snapshot

Efficient Isolation of Dihydropyranocoumarins and Simple Coumarins from Mutellina purpurea Fruits

inferredcites →https://doi.org/10.1073/pnas.0508575102openalex-snapshot

Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent

inferredcites →https://doi.org/10.1074/jbc.m210241200openalex-snapshot

Crystal Structure of Human Butyrylcholinesterase and of Its Complexes with Substrate and Products

inferredcites →https://doi.org/10.1111/j.1600-0773.1983.tb01095.xopenalex-snapshot

Coronary Vasodilatory, Spasmolytic and cAMP‐Phosphodiesterase Inhibitory Properties of Dihydropyranocoumarins and Dihydrofuranocoumarins

inferredcites →https://doi.org/10.1248/cpb.48.1429openalex-snapshot

Medicinal Foodstuffs. XX. Vasorelaxant Active Constituents from the Roots of Angelica furcijuga KITAGAWA: Structures of Hyuganins A, B, C, and D.

inferredcites →https://doi.org/10.1515/znc-2008-5-610openalex-snapshot

Coumarin, Anthroquinone and Stilbene Derivatives with Anticholinesterase Activity

inferredcites →https://doi.org/10.1586/ern.12.43openalex-snapshot

New and emerging treatments for Alzheimer’s disease

inferredcites →https://doi.org/10.2174/138955711796575434openalex-snapshot

An Overview on Natural Cholinesterase Inhibitors - A Multi-Targeted Drug Class - and Their Mass Production

inferredcites →https://doi.org/10.2174/15680266113139990142openalex-snapshot

Natural Products as Sources of New Lead Compounds for the Treatment of Alzheimer’s Disease

inferredcites →https://doi.org/10.2174/1568026615666150427113103openalex-snapshot

Coumarins: Auspicious Cholinesterase and Monoamine Oxidase Inhibitors

inferredcites →https://doi.org/10.2174/1568026615666150610143510openalex-snapshot

Computer Aided Drug Design Studies in the Discovery of Secondary Metabolites Targeted Against Age-Related Neurodegenerative Diseases

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4633265openalex-extracted

Carltonine-Derived Compounds for Targeted Butyrylcholinesterase Inhibition

inferred← citeshttps://doi.org/10.1002/9780470027318.a9925.pub2openalex-snapshot

Coumarins: Analytical and Preparative Techniques

inferred← citeshttps://doi.org/10.1002/9781119794127.ch3openalex-snapshot

Drug Discovery from Medicinal Plants against Alzheimer's Disease

inferred← citeshttps://doi.org/10.1002/ardp.201800247openalex-snapshot

Synthesis, CYP 450 evaluation, and docking simulation of novel 4‐aminopyridine and coumarin derivatives

inferred← citeshttps://doi.org/10.1002/cbdv.201800662openalex-snapshot

Clinanthus microstephium, an Amaryllidaceae Species with Cholinesterase Inhibitor Alkaloids: Structure−Activity Analysis of Haemanthamine Skeleton Derivatives

inferred← citeshttps://doi.org/10.1002/cbdv.201900017openalex-snapshot

Profiling Auspicious Butyrylcholinesterase Inhibitory Activity of Two Herbal Molecules: Hyperforin and Hyuganin C

inferred← citeshttps://doi.org/10.1002/cbdv.201900333openalex-snapshot

Metabolite Profiling by Hyphenated Liquid Chromatographic Mass Spectrometric Technique (HPLC‐DAD‐ESI‐Q‐TOF‐MS/MS) and Neurobiological Potential of Haplophyllum sahinii and H. vulcanicum Extracts

inferred← citeshttps://doi.org/10.1002/cbdv.202200315openalex-snapshot

Evaluation of Anti‐Alzheimer Activity of Synthetic Coumarins by Combination of in Vitro and in Silico Approaches

inferred← citeshttps://doi.org/10.1002/slct.201803672openalex-snapshot

Phyto‐Tacrine Hybrids as Promising Drugs to Treat Alzheimer's Disease

inferred← citeshttps://doi.org/10.1007/978-3-030-04624-8_26openalex-snapshot

Nutraceuticals for Cognitive Dysfunction

inferred← citeshttps://doi.org/10.1007/s10876-021-02099-0openalex-snapshot

Bioactive Molecules Coated Silver Oxide Nanoparticle Synthesis from Curcuma zanthorrhiza and HR-LCMS Monitored Validation of Its Photocatalytic Potency Towards Malachite Green Degradation

inferred← citeshttps://doi.org/10.1016/b978-0-12-813374-3.00014-4openalex-snapshot

Therapeutic Evaluation of Herbs With Enzyme Inhibition Studies

inferred← citeshttps://doi.org/10.1016/b978-0-12-817901-7.00009-5openalex-snapshot

Neuroprotective potential of phytochemicals via in silico molecular docking techniques

inferred← citeshttps://doi.org/10.1016/b978-0-443-15650-2.00003-9openalex-snapshot

In the design and development of neurotherapeutics agents

inferred← citeshttps://doi.org/10.1016/b978-0-443-23763-8.00034-8openalex-snapshot

Neuroprotection induced by coumarins in central nervous system disease models

inferred← citeshttps://doi.org/10.1016/j.biopha.2021.111609openalex-snapshot

Potential therapeutic natural products against Alzheimer's disease with Reference of Acetylcholinesterase

inferred← citeshttps://doi.org/10.1016/j.biopha.2023.114898openalex-snapshot

Pteryxin suppresses osteoclastogenesis and prevents bone loss via inhibiting the MAPK/Ca2+ signaling pathways mediated by ROS

inferred← citeshttps://doi.org/10.1016/j.bjp.2019.08.001openalex-snapshot

Selective BuChE inhibitory activity, chemical composition, and enantiomer content of the volatile oil from the Ecuadorian plant Clinopodium brownei

inferred← citeshttps://doi.org/10.1016/j.ejmech.2025.117401openalex-snapshot

Phytomolecules as Alzheimer's therapeutics: A comprehensive review

inferred← citeshttps://doi.org/10.1016/j.fct.2017.08.003openalex-snapshot

IXth International Symposium on Natural Products Chemistry and its Applications (IX-ISNPCA), Termas de Chillan, Chillan, Chile

inferred← citeshttps://doi.org/10.1016/j.foodchem.2018.08.044openalex-snapshot

Report on the 2nd International Symposium on Phytochemicals in Medicine and Food (4–7 April 2017, FuZhou, China)

inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2018.09.014openalex-snapshot

Cholinesterases inhibition studies of biological active compounds from the rhizomes of Alpinia officinarum Hance and in silico molecular dynamics

inferred← citeshttps://doi.org/10.1016/j.jep.2021.114753openalex-snapshot

Pteryxin attenuates LPS-induced inflammatory responses and inhibits NLRP3 inflammasome activation in RAW264.7 cells

inferred← citeshttps://doi.org/10.1016/j.jep.2021.114924openalex-snapshot

Protective effect of pteryxin on LPS-induced acute lung injury via modulating MAPK/NF-κB pathway and NLRP3 inflammasome activation

inferred← citeshttps://doi.org/10.1016/j.molstruc.2022.132799openalex-snapshot

In vitro studies of a series of synthetic compounds for their anti-acetylcholinesterase activities identified arylpyrano[2,3-f]coumarins as hit compounds

inferred← citeshttps://doi.org/10.1016/j.phymed.2018.10.030openalex-snapshot

High-performance counter-current chromatography isolation and initial neuroactivity characterization of furanocoumarin derivatives from Peucedanum alsaticum L (Apiaceae)

inferred← citeshttps://doi.org/10.1016/j.phytol.2021.05.001openalex-snapshot

Butyrylcholinesterase-inhibiting natural coumarin molecules as potential leads

inferred← citeshttps://doi.org/10.1016/j.prmcm.2024.100405openalex-snapshot

Biological potential and therapeutic effectiveness of pteryxin in medicine. A viable alternative to current remedies for the treatment of human disorders

inferred← citeshttps://doi.org/10.1016/j.sajb.2019.01.020openalex-snapshot

Antioxidant and anticholinesterase potential of Ferulago cassia with farther bio-guided isolation of active coumarin constituents

inferred← citeshttps://doi.org/10.1038/s41598-020-78782-5openalex-snapshot

Acetylcholinesterase and butyrylcholinesterase inhibitory activities of khellactone coumarin derivatives isolated from Peucedanum japonicum Thurnberg

inferred← citeshttps://doi.org/10.1039/d4md00060aopenalex-snapshot

Carltonine-derived compounds for targeted butyrylcholinesterase inhibition

inferred← citeshttps://doi.org/10.1039/d6ra01662fopenalex-snapshot

Design, synthesis, and evaluation of pyrano[3,2- c ]coumarin derivatives for simultaneous targeting of amyloid-β 42 and acetylcholinesterase in transgenic AD model of Drosophila

inferred← citeshttps://doi.org/10.1080/14756366.2018.1491847openalex-snapshot

The insight of in vitro and in silico studies on cholinesterase inhibitors from the roots of Cimicifuga dahurica (Turcz.) Maxim.

inferred← citeshttps://doi.org/10.1134/s1070363225606751openalex-snapshot

Synthesis of 3- and 3,6-Substituted Pyranocoumarins as Starting Structures Towards Compounds Having Neuroprotective Activity

inferred← citeshttps://doi.org/10.1155/2021/5965061openalex-snapshot

Phytochemical Analysis and Evaluation of Biological Activity of Lawsonia inermis Seeds Related to Alzheimer’s Disease

inferred← citeshttps://doi.org/10.1186/s12906-021-03464-2openalex-snapshot

Phytochemical analysis and anticancer activity of Falcaria vulgaris Bernh growing in Moghan plain, northwest of Iran

inferred← citeshttps://doi.org/10.18311/jeoh/2022/29511openalex-snapshot

Therapeutic Efficacy of Natural Phytochemicals as Acetylcholinesterase Inhibitors Against Alzheimer’s Disease

inferred← citeshttps://doi.org/10.21203/rs.3.rs-530162/v1openalex-snapshot

Chemical Characterization and Evaluation of Anticancer Effect of Falcaria vulgaris via Induction of Apoptosis

inferred← citeshttps://doi.org/10.2174/0929867328666210827152914openalex-snapshot

Molecular Effects of Pteryxin and Scopoletin in the 5xFAD Alzheimer’s Disease Mouse Model

inferred← citeshttps://doi.org/10.2174/1386207323666200127145246openalex-snapshot

A Recent Look into Natural Products that have Potential to Inhibit Cholinesterases and Monoamine Oxidase B: Update for 2010-2019

inferred← citeshttps://doi.org/10.2174/1568026619666191203113745openalex-snapshot

Progress in Target Drug Molecules for Alzheimer's Disease

inferred← citeshttps://doi.org/10.2174/1568026620666200616142753openalex-snapshot

A Multi-layered Variable Selection Strategy for QSAR Modeling of Butyrylcholinesterase Inhibitors

inferred← citeshttps://doi.org/10.33320/maced.pharm.bull.2022.68.02.001openalex-snapshot

Phenolic phytochemicals for treatment of Alzheimer’s condition - a review

inferred← citeshttps://doi.org/10.33320/maced.pharm.bull.2022.68.04.016openalex-snapshot

Phytocomponents in treatment of Alzheimer condition

inferred← citeshttps://doi.org/10.3389/fbioe.2024.1387146openalex-snapshot

Rational design of a near-infrared fluorescent probe for monitoring butyrylcholinesterase activity and its application in development of inhibitors

inferred← citeshttps://doi.org/10.3389/fchem.2022.1063284openalex-snapshot

Butenolide derivatives from Aspergillus terreus selectively inhibit butyrylcholinesterase

inferred← citeshttps://doi.org/10.3389/fphar.2021.639651openalex-snapshot

Role of Plant-Derived Natural Compounds in Experimental Autoimmune Encephalomyelitis: A Review of the Treatment Potential and Development Strategy

inferred← citeshttps://doi.org/10.3389/fphar.2025.1698826openalex-snapshot

Pteryxin enhances human NK-cell cytotoxicity by upregulating NKp30, NKp46, and 2B4 via ERK/AKT signaling

inferred← citeshttps://doi.org/10.3390/molecules23092182openalex-snapshot

Natural Scaffolds with Multi-Target Activity for the Potential Treatment of Alzheimer’s Disease

inferred← citeshttps://doi.org/10.3390/molecules26185582openalex-snapshot

Non-Alkaloid Cholinesterase Inhibitory Compounds from Natural Sources

inferred← citeshttps://doi.org/10.3390/molecules29020315openalex-snapshot

Benzofuran Derivatives from Cortex Mori Radicis and Their Cholinesterase-Inhibitory Activity

inferred← citeshttps://doi.org/10.3390/molecules29153514openalex-snapshot

Naturally Inspired Coumarin Derivatives in Alzheimer’s Disease Drug Discovery: Latest Advances and Current Challenges

inferred← citeshttps://doi.org/10.56238/globalhealthprespesc-039openalex-snapshot

Bibliometric study of chemical compounds based on medicinal plants anti-Alzheimer

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.